---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-041723"
form_type: "8-K"
ticker: null
cik: "0000819050"
company_name: "Fresh Tracks Therapeutics, Inc."
filed_at: "2023-12-18T23:59:59+00:00"
generated_at: "2026-06-07T11:34:00.243013+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Fresh Tracks Therapeutics to be suspended from Nasdaq on Dec 19; plans liquidation and dissolution

## Summary
- Stock to be suspended from Nasdaq at open on Dec 19, 2023; expects trading to begin on OTC market.
- Board withdrew appeal of Nasdaq delisting notice on Dec 15 in preparation for planned dissolution.
- Special meeting of stockholders reconvened for Dec 27 to vote on Plan of Liquidation and Dissolution.
- If stockholders do not approve dissolution, company intends to seek judicial dissolution, which would reduce cash distributions.

## SEC filing metadata
- accession: 0001628280-23-041723
- form_type: 8-K
- cik: 0000819050
- company_name: Fresh Tracks Therapeutics, Inc.
- filed_at: 2023-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/819050/000162828023041723/0001628280-23-041723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/819050/000162828023041723/frtx-20231215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-041723
- JSON: https://secwatch.observer/filing/0001628280-23-041723.json
- Plain text: https://secwatch.observer/filing/0001628280-23-041723.txt

## Key facts
- Listing & Compliance Notices
  Fresh Tracks Therapeutics, Inc. received a nasdaq noncompliance notice notice regarding other.
  - Exchange: nasdaq
  - Notice: noncompliance notice
  source text: October 17, 2023, the Company requested an appeal (the “Appeal”) through a hearing before the Nasdaq Hearings Panel (the “Panel”), which stayed the suspension and delisting action pending the Panel’s decision. On December 15, 2023, in preparation for the planned liquidation and dissolution (the “Dissolution”) of the Company, the Company’s Board of Directors approved the withdrawal of the Appeal and authorized the officers of the Company to seek to delist the Company’s common stock from Nasdaq. The Company also notified Nasdaq of its decision to withdraw the Appeal. Also on December 15, 2023, f
  evidence_url: https://www.sec.gov/Archives/edgar/data/819050/000162828023041723/0001628280-23-041723-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.